Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Journal of Diabetes and Metabolic Disorders
|
June 27, 2024
Obesity as a risk factor in atrial fibrillation and heart failure
Jakub Jurica, Martin Jozef Péč, Jakub Benko, et al.
European Journal of Case Reports in Internal Medicine
|
May 8, 2024
A Fast-Growing Myxoma of the Left Atrium
Jakub Benko, Martin Jozef Péč, Marek Cingel, et al.
Journal of Diabetes Research
|
March 17, 2022
Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
Jakub Benko, Matej Samoš, Tomáš Bolek, et al.
Frontiers in Cardiovascular Medicine
|
October 13, 2025
Right atrial and right ventricular strain in patients with acute decompensated heart failure: a pilot study
Jakub Jurica, Martin Jozef Péč, Marek Cingel, et al.
Medicine
|
July 1, 2022
Rotational thromboelastometry in patients with type 2 diabetes and mild COVID-19 pneumonia: A pilot prospective study
Tomáš Bolek, Matej Samoš, Ingrid Škorňová, et al.
Journal of Clinical Medicine
|
December 11, 2022
Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?
Peter Blaško, Matej Samoš, Tomáš Bolek, et al.
Clinical Nutrition ESPEN
|
December 20, 2025
Effect of semaglutide with metformin for weight loss and fertility in polycystic ovary syndrome (PCOS) patients with obesity: A pilot prospective study
Tomáš Bolek, Petra Turňová, Svetlana Janošova, et al.
Diagnostics (Basel, Switzerland)
|
July 13, 2024
Left Ventricular and Atrial Deformation in Patients with Acute Decompensated Heart Failure: A Pilot Study
Jakub Jurica, Martin Jozef Péč, Marek Cingel, et al.
Journal of Clinical Medicine
|
March 11, 2023
COVID-19 and the Response to Antiplatelet Therapy
Tomáš Bolek, Matej Samoš, Jakub Jurica, et al.
Scientific Reports
|
June 3, 2026
Real-world use of submaximal doses of long-acting GLP-1 receptor agonist semaglutide in patients with obesity: a prospective observational study
Zuzana Miertová, Patrik Lecký, Boris Focko, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Journal of Diabetes and Metabolic Disorders
|
June 27, 2024
Obesity as a risk factor in atrial fibrillation and heart failure
Jakub Jurica, Martin Jozef Péč, Jakub Benko, et al.
European Journal of Case Reports in Internal Medicine
|
May 8, 2024
A Fast-Growing Myxoma of the Left Atrium
Jakub Benko, Martin Jozef Péč, Marek Cingel, et al.
Journal of Diabetes Research
|
March 17, 2022
Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
Jakub Benko, Matej Samoš, Tomáš Bolek, et al.
Frontiers in Cardiovascular Medicine
|
October 13, 2025
Right atrial and right ventricular strain in patients with acute decompensated heart failure: a pilot study
Jakub Jurica, Martin Jozef Péč, Marek Cingel, et al.
Medicine
|
July 1, 2022
Rotational thromboelastometry in patients with type 2 diabetes and mild COVID-19 pneumonia: A pilot prospective study
Tomáš Bolek, Matej Samoš, Ingrid Škorňová, et al.
Journal of Clinical Medicine
|
December 11, 2022
Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?
Peter Blaško, Matej Samoš, Tomáš Bolek, et al.
Clinical Nutrition ESPEN
|
December 20, 2025
Effect of semaglutide with metformin for weight loss and fertility in polycystic ovary syndrome (PCOS) patients with obesity: A pilot prospective study
Tomáš Bolek, Petra Turňová, Svetlana Janošova, et al.
Diagnostics (Basel, Switzerland)
|
July 13, 2024
Left Ventricular and Atrial Deformation in Patients with Acute Decompensated Heart Failure: A Pilot Study
Jakub Jurica, Martin Jozef Péč, Marek Cingel, et al.
Journal of Clinical Medicine
|
March 11, 2023
COVID-19 and the Response to Antiplatelet Therapy
Tomáš Bolek, Matej Samoš, Jakub Jurica, et al.
Scientific Reports
|
June 3, 2026
Real-world use of submaximal doses of long-acting GLP-1 receptor agonist semaglutide in patients with obesity: a prospective observational study
Zuzana Miertová, Patrik Lecký, Boris Focko, et al.
Page
of 2